| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Outline of Final Research Achievements |
Metabolic syndrome is emerging as a major public health problem. Since obesity is a predominant risk factor for metabolic syndrome, to provide effective approaches for prevention and treatment of obesity are strongly desired. Brown adipocytes specialize in dissipating energy as heat. Therefore, utilizing brown adipose tissue is attracting attention as a new therapeutic strategy for the treatment of obesity. We have identified CREG1 as a novel regulator of brown adipogenesis. In this study, we investigated the mechanism of brown adipogenesis by CREG1 and revealed that CREG1 exerts its function through the thyroid hormone system. Furthermore, we clarified that CREG1 has an anti-obesity effect on high-fat diet-induced obesity and improves glucose tolerance.
|
